Insider Sale: Director B Parshall Sells 5,000 Shares of Cytokinetics Inc (CYTK)

Cytokinetics Inc is a biopharmaceutical company focusing on developing muscle-modulating therapeutics. Recent insider selling trends and stock valuation indicate potential overvaluation. Investors may find insider transactions relevant for stock performance evaluation.